Results 101 to 110 of about 3,842 (127)
Some of the next articles are maybe not open access.
Drugs, 1998
The progestogen dienogest exhibits highly selective binding to the progesterone receptor. It has high progestational and significant antiandrogenic activity, but only moderate antigonadotrophic activity. Dienogest inhibits ovulation, produces secretory transformation of the endometrium and has antiproliferative effects.
R H, Foster, M I, Wilde
+5 more sources
The progestogen dienogest exhibits highly selective binding to the progesterone receptor. It has high progestational and significant antiandrogenic activity, but only moderate antigonadotrophic activity. Dienogest inhibits ovulation, produces secretory transformation of the endometrium and has antiproliferative effects.
R H, Foster, M I, Wilde
+5 more sources
Drugs, 2002
Estradiol valerate 2mg/dienogest 2mg is an oral estrogen/ progestogen formulation that has been approved throughout the European Union for the treatment of climacteric symptoms in postmenopausal women. Dienogest is a progestogen that combines the properties of both progesterone and 19-nortestosterone derivatives.
Keri, Wellington, Caroline M, Perry
+5 more sources
Estradiol valerate 2mg/dienogest 2mg is an oral estrogen/ progestogen formulation that has been approved throughout the European Union for the treatment of climacteric symptoms in postmenopausal women. Dienogest is a progestogen that combines the properties of both progesterone and 19-nortestosterone derivatives.
Keri, Wellington, Caroline M, Perry
+5 more sources
pharma-kritik, 2022
Mit Dienogest als Monopräparat steht eine vergleichsweise gut dokumentierte Behandlungsoption bei Endometriose zur Verfügung. Ob sich dieses Gestagen aber signifikant besser auf die Endometriose-bedingten Schmerzen auswirkt als andere Therapien (z.B. andere Gestagene), ist bisher nicht nachgewiesen.
openaire +1 more source
Mit Dienogest als Monopräparat steht eine vergleichsweise gut dokumentierte Behandlungsoption bei Endometriose zur Verfügung. Ob sich dieses Gestagen aber signifikant besser auf die Endometriose-bedingten Schmerzen auswirkt als andere Therapien (z.B. andere Gestagene), ist bisher nicht nachgewiesen.
openaire +1 more source
Maturitas, 2012
Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a cyanomethyl instead of an ethinyl group at the C-17 position, which may make the compound elicit fewer hepatic effects than other C-19 nortestosterone derivatives. Its similarity to norethisterone is reflected in its high endometrial efficacy, which could explain the high ...
Xiangyan, Ruan, H, Seeger, A O, Mueck
openaire +3 more sources
Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a cyanomethyl instead of an ethinyl group at the C-17 position, which may make the compound elicit fewer hepatic effects than other C-19 nortestosterone derivatives. Its similarity to norethisterone is reflected in its high endometrial efficacy, which could explain the high ...
Xiangyan, Ruan, H, Seeger, A O, Mueck
openaire +3 more sources
Dienogest - ein neues Progestagen
Archives of Gynecology and Obstetrics, 1993Dienogest stellt sich nach diesen Untersuchungen als ein Gestagen mit fehlender Androgenitat und weitgehender metabolischer Vertraglichkeit dar, das als eine Erweitwerung des verfugbaren Spektrums begrust werden kann.
G. Klinger, W. Carol, M. Oettel
openaire +1 more source
Drugs, 2009
Estradiol valerate/dienogest is an oral contraceptive for women that combines the natural estrogen estradiol with the 19-nortestosterone derivative dienogest in a four-phasic formulation. Estradiol valerate/dienogest demonstrated contraceptive efficacy in a large (n = 1377), noncomparative, multicentre study in women aged 18-50 years, with 13 ...
Sheridan M, Hoy, Lesley J, Scott
openaire +2 more sources
Estradiol valerate/dienogest is an oral contraceptive for women that combines the natural estrogen estradiol with the 19-nortestosterone derivative dienogest in a four-phasic formulation. Estradiol valerate/dienogest demonstrated contraceptive efficacy in a large (n = 1377), noncomparative, multicentre study in women aged 18-50 years, with 13 ...
Sheridan M, Hoy, Lesley J, Scott
openaire +2 more sources
Ethinylestradiol/Dienogest in Oral Contraception
Drugs, 2010The low-dose combined oral contraceptive of ethinylestradiol 30 microg and dienogest 2 mg was launched in Germany in 1995, and is now the most commonly prescribed oral contraceptive in this country. Dienogest is a novel 19-nortestosterone-derived progestin with a unique pharmacokinetic and pharmacological profile, including antiandrogenic properties ...
openaire +2 more sources